List your tool

Head to head · 2026

PathAI vs Proscia

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

PathAI

First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp

4.3Not listed

Visit PathAI (opens PathAI in a new tab)

Proscia

FDA-cleared digital pathology platform for primary diagnosis and biomarker research

4.3Not listed

Visit Proscia (opens Proscia in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: PathAI does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Tie

    4.3 against 4.3

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onPathAIProscia
Our rating4.34.3
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • AISight Dx analyzes digital pathology slide images to assist diagnosis
  • FDA 510(k) clearance for primary diagnosis in clinical settings, June 2025
  • Predetermined Change Control Plan allows faster future software updates
  • Expanded Labcorp collaboration deploying nationwide as of February 2026
  • FDA Breakthrough Device Designation for PathAssist Derm dermatopathology tool
  • FDA-cleared for primary clinical diagnosis in AP-Dx
  • Concentriq AP, AP-Dx and LS configurations
  • Biomarker research and clinical trial workflows
  • Cloud deployment
  • Predetermined Change Control Plan for regulatory compliance
Pros
  • Genuine FDA clearance for primary diagnosis, not just an assistive tool
  • Predetermined Change Control Plan speeds up future regulatory-approved updates
  • National-scale deployment through Labcorp validates real clinical trust
  • FDA clearance for primary diagnosis, not just research viewing
  • Deployed across 4,000 hospitals and 16 of the top 20 pharma companies
  • Rated highest in KLAS 2026 in both the US and Europe
Cons
  • Enterprise quote-based pricing requires a sales conversation, no published rates
  • Built specifically for pathology labs, not applicable to other clinical specialties
  • Regulatory-cleared medical device status means slower iteration than software-only tools
  • No published pricing
  • Requires compatible scanning hardware
  • Adoption is a laboratory-wide programme, not a purchase
CompanyPathAI, founded 2016Proscia Inc.

Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.

FAQ

Questions people ask

Is PathAI better than Proscia?

In our reviews PathAI scores 4.3 and Proscia scores 4.3. The better pick depends on the job. PathAI: First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp. Proscia: FDA-cleared digital pathology platform for primary diagnosis and biomarker research.

Which is cheaper, PathAI or Proscia?

PathAI: see pricing. Proscia: see pricing.

Do PathAI and Proscia have free plans?

Neither lists a free plan.

More comparisons

PathAI compared with

All PathAI alternatives

Proscia compared with

All Proscia alternatives